KOSPI · Healthcare · ₩262B
₩19,360+1.04%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 1.4% · as of 26.10.27
Among 98 제약 peers
Quarterly Revenue Growth
“판매 성장은 이어졌고 이제 수익성 회복이 관건이에요.”
In the company's words · 2026 2분기 filing